(Q42602858)

3 November 2017

title

Levosimendan decreases intracranial pressure after hypothermic circulatory arrest in a porcine model (English)

1 reference

3 November 2017

Hanna Jensen

1

1 reference

3 November 2017

Rimpiläinen Eija

2

1 reference

3 November 2017

Mäkelä Tuomas

3

1 reference

3 November 2017

Mäkelä Jussi

4

1 reference

3 November 2017

Yannopoulos Fredrik

5

1 reference

3 November 2017

Alestalo Kirsi

6

1 reference

3 November 2017

Pokela Matti

7

1 reference

3 November 2017

Kiviluoma Kai

8

1 reference

3 November 2017

Tuominen Hannu

9

1 reference

3 November 2017

Anttila Vesa

10

1 reference

3 November 2017

Juvonen Tatu

11

1 reference

3 November 2017

publication date

31 May 2011

1 reference

Scandinavian Cardiovascular Journal

3 November 2017

published in

1 reference

3 November 2017

volume

45

1 reference

3 November 2017

issue

5

1 reference

3 November 2017

page(s)

307-315

1 reference

Brain protection during surgery of the aortic arch

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Hypothermic circulatory arrest during ascending and aortic arch surgery: the theoretical impact of different cerebral perfusion techniques and other methods of cerebral protection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Levosimendan in cardiac surgery: current best available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Vasodilating mechanisms of levosimendan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Nuclear factor kappa-B and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

The role of cytokines in the neuropathology of stroke and neurotrauma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14017431.2011.583356

10.3109/14017431.2011.583356

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference